477 related articles for article (PubMed ID: 34556169)
1. Concomitant familial hypocalciuric hypercalcemia and single parathyroid adenoma: a case report.
Marstrand SD; Tofteng CL; Jarløv A; Borgwardt L; Schwarz P
J Med Case Rep; 2021 Sep; 15(1):471. PubMed ID: 34556169
[TBL] [Abstract][Full Text] [Related]
2. Misleading localization by
Mukhtar NN; Abouzied MEM; Alqahtani MH; Hammami MM
BMC Endocr Disord; 2021 Jan; 21(1):20. PubMed ID: 33499837
[TBL] [Abstract][Full Text] [Related]
3. Persistent hypercalcemia with similar familial Hypocalciuric hypercalcemia features: a case report and literature review.
Zahedi M; Hizomi Arani R; Rafati M; Amouzegar A; Hadaegh F
BMC Endocr Disord; 2021 Nov; 21(1):220. PubMed ID: 34736428
[TBL] [Abstract][Full Text] [Related]
4. Familial Hypocalciuric Hypercalcemia as an Atypical Form of Primary Hyperparathyroidism.
Marx SJ
J Bone Miner Res; 2018 Jan; 33(1):27-31. PubMed ID: 29115694
[TBL] [Abstract][Full Text] [Related]
5. Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism.
Christensen SE; Nissen PH; Vestergaard P; Heickendorff L; Rejnmark L; Brixen K; Mosekilde L
Eur J Endocrinol; 2008 Dec; 159(6):719-27. PubMed ID: 18787045
[TBL] [Abstract][Full Text] [Related]
6. Familial hypocalciuric hypercalcemia in an index male: grey zones of the differential diagnosis from primary hyperparathyroidism in a 13-year clinical follow up.
Zajíčková K; Dvořáková M; Moravcová J; Včelák J; Goltzman D
Physiol Res; 2020 Sep; 69(Suppl 2):S321-S328. PubMed ID: 33094630
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid hormone-dependent familial hypercalcemia with low measured PTH levels and a presumptive novel pathogenic mutation in CaSR.
Mahajan A; Buse J; Kline G
Osteoporos Int; 2020 Jan; 31(1):203-207. PubMed ID: 31641801
[TBL] [Abstract][Full Text] [Related]
8. Calcium-sensing-related gene mutations in hypercalcaemic hypocalciuric patients as differential diagnosis from primary hyperparathyroidism: detection of two novel inactivating mutations in an Italian population.
Stratta P; Merlotti G; Musetti C; Quaglia M; Pagani A; Izzo C; Radin E; Airoldi A; Baorda F; Palladino T; Leone MP; Guarnieri V
Nephrol Dial Transplant; 2014 Oct; 29(10):1902-9. PubMed ID: 25104082
[TBL] [Abstract][Full Text] [Related]
9. Pro-FHH: A Risk Equation to Facilitate the Diagnosis of Parathyroid-Related Hypercalcemia.
Bertocchio JP; Tafflet M; Koumakis E; Maruani G; Vargas-Poussou R; Silve C; Nissen PH; Baron S; Prot-Bertoye C; Courbebaisse M; Souberbielle JC; Rejnmark L; Cormier C; Houillier P
J Clin Endocrinol Metab; 2018 Jul; 103(7):2534-2542. PubMed ID: 29727008
[TBL] [Abstract][Full Text] [Related]
10. Think twice: a rare calcium sensing receptor mutation and a new diagnosis of familial hypocalciuric hypercalcaemia.
Tellam JJ; Abdulrasool G; Ciin LCH
Endocrinol Diabetes Metab Case Rep; 2020 Jun; 2020():. PubMed ID: 32698162
[TBL] [Abstract][Full Text] [Related]
11. Differentiating familial hypocalciuric hypercalcemia from primary hyperparathyroidism.
Shinall MC; Dahir KM; Broome JT
Endocr Pract; 2013; 19(4):697-702. PubMed ID: 23425644
[TBL] [Abstract][Full Text] [Related]
12. Coexistence of a Calcium-Sensing Receptor Mutation and Primary Hyperparathyroidism.
Russell P; Antony MA
Cureus; 2023 Oct; 15(10):e46980. PubMed ID: 38021951
[TBL] [Abstract][Full Text] [Related]
13. Inactivating calcium-sensing receptor mutations in patients with primary hyperparathyroidism.
Frank-Raue K; Leidig-Bruckner G; Haag C; Schulze E; Lorenz A; Schmitz-Winnenthal H; Raue F
Clin Endocrinol (Oxf); 2011 Jul; 75(1):50-5. PubMed ID: 21521328
[TBL] [Abstract][Full Text] [Related]
14. [Hereditary variants of primary hyperparathyroidism--MEN1, MEN2, HPT-JT, FHH, FIHPT].
Frank-Raue K; Leidig-Bruckner G; Lorenz A; Rondot S; Haag C; Schulze E; Büchler M; Raue F
Dtsch Med Wochenschr; 2011 Sep; 136(38):1889-94. PubMed ID: 21915802
[TBL] [Abstract][Full Text] [Related]
15. A Novel Missense
Bletsis P; Metzger R; Nelson JA; Gasparini J; Alsayed M; Milas M
AACE Clin Case Rep; 2022; 8(5):194-198. PubMed ID: 36189134
[TBL] [Abstract][Full Text] [Related]
16. Genetics of hereditary forms of primary hyperparathyroidism.
English KA; Lines KE; Thakker RV
Hormones (Athens); 2024 Mar; 23(1):3-14. PubMed ID: 38038882
[TBL] [Abstract][Full Text] [Related]
17. Familial Hypocalciuric Hypercalcemia Types 1 and 3 and Primary Hyperparathyroidism: Similarities and Differences.
Vargas-Poussou R; Mansour-Hendili L; Baron S; Bertocchio JP; Travers C; Simian C; Treard C; Baudouin V; Beltran S; Broux F; Camard O; Cloarec S; Cormier C; Debussche X; Dubosclard E; Eid C; Haymann JP; Kiando SR; Kuhn JM; Lefort G; Linglart A; Lucas-Pouliquen B; Macher MA; Maruani G; Ouzounian S; Polak M; Requeda E; Robier D; Silve C; Souberbielle JC; Tack I; Vezzosi D; Jeunemaitre X; Houillier P
J Clin Endocrinol Metab; 2016 May; 101(5):2185-95. PubMed ID: 26963950
[TBL] [Abstract][Full Text] [Related]
18. Brown tumor due to primary hyperparathyroidism in a familial case: a case report.
Diao Z; Zhang J; Zhao J; Sun W; Pu Z
BMC Endocr Disord; 2023 Oct; 23(1):214. PubMed ID: 37807045
[TBL] [Abstract][Full Text] [Related]
19. Primary hyperparathyroidism and familial hypocalciuric hypercalcemia: relationships and clinical implications.
Eldeiry LS; Ruan DT; Brown EM; Gaglia JL; Garber JR
Endocr Pract; 2012; 18(3):412-7. PubMed ID: 22232026
[TBL] [Abstract][Full Text] [Related]
20. THE FAMILIAL HYPOCALCIURIC HYPERCALCEMIA PRESENTED WITH ADVANCED HYPERCALCEMIA AND EXTREMELY HIGH PARATHORMON LEVELS (CASE REPORT).
Cengiz H; Varim C; Demirci T; Cetin S; Karacaer C; Koçer H
Georgian Med News; 2021 Oct; (319):108-111. PubMed ID: 34749333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
